about
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virusNaloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention studyPerspective: test and treat this silent killer.Testing Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence RatesEstimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progressionMBL2and Hepatitis C Virus Infection among Injection Drug UsersNaturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patientsHepatitis C Virus (HCV)–Specific Immune Responses of Long‐Term Injection Drug Users Frequently Exposed to HCVAn outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndromeReinterpreting ethnic patterns among white and African American men who inject heroin: a social science of medicine approachAccess to treatment for hepatitis C virus infection: time to put patients first.Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts.Community characteristics associated with HIV risk among injection drug users in the San Francisco Bay Area: a multilevel analysisRisk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for preventionTemporal changes in HCV genotype distribution in three different high risk populations in San Francisco, CaliforniaGenetic variation in CLDN1 and susceptibility to hepatitis C virus infectionHepatitis C virus-specific T-cell immune responses in seronegative injection drug usersPrevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial.Toward a more accurate estimate of the prevalence of hepatitis C in the United States.Human immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug user exposure.Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users.Infrequent reinfection after successful treatment for hepatitis C virus infection in injection drug usersWhat's community got to do with it? Implementation models of syringe exchange programsInduction of CXCR3- and CCR5-associated chemokines during acute hepatitis C virus infectionPrevention and treatment of hepatitis C in injection drug users.IL28B rs12979860 genotype and spontaneous clearance of hepatitis C virus in a multi-ethnic cohort of injection drug users: evidence for a supra-additive associationSpontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustionInterferon Lambda 4 Genotype Is Not Associated with Recurrence of Oral or Genital HerpesHCV RNA levels in a multiethnic cohort of injection drug users: human genetic, viral and demographic associationsComparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.HIV prevalence and risk behaviors among men who have sex with men and inject drugs in San FranciscoSecondary syringe exchange among injection drug usersAttitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay AreaFatal heroin-related overdose in San Francisco, 1997-2000: a case for targeted intervention.Incentives and accessibility: a pilot study to promote adherence to TB prophylaxis in a high-risk community.Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000.Hepatitis C screening: getting it right.The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use.Active opioid use does not attenuate the humoral responses to inactivated influenza vaccine.Racial/ethnic differences in spontaneous HCV clearance in HIV infected and uninfected women.
P50
Q24307721-E736E2AE-CA21-4BD9-97C3-5004B4618762Q24650146-913C64D6-48CB-41C7-8F9B-17E48B57B80AQ27332812-17915616-370F-4F66-9EA3-21E23C2D4026Q27485369-2D31DE1D-E0FF-4AC7-9EAF-EAA33CED9E31Q27485372-5E9DA607-2848-483F-BCA0-FC141E229892Q27486245-B4DA9DC4-21D7-42E5-948C-9DCFDA2BFA2FQ27487949-D6798CFF-8E0A-40BA-BEEE-C451652696A7Q27488816-12F111C6-0D62-43F5-AC90-9AB3BBC1C584Q28208180-779FDEAE-C0D5-474F-A3BE-D56D158CCADBQ28469064-A9A6E116-3094-43A1-B2DE-AEAB2DA93C59Q30248987-23BFEF40-F46F-4B26-ADE7-820D3E7064B6Q30590832-33A55F66-721E-4D33-9C31-61657A46F698Q33291964-0D6C4502-20F6-4AC1-9E64-B15C63EEE3CCQ33707925-AE4738E0-F912-4418-816B-023D9BE5CB6DQ33978978-0402985D-2D21-4D53-8894-F771E1DBE50AQ34064240-845F0C1B-1BA2-4E4A-860D-6889C12186E4Q34381567-E45A2D58-036B-4CF0-9EAA-58937B86D23CQ34460893-7884EB34-5FCF-443A-8683-5F5151834C46Q34484872-4AF64250-54B4-4964-893E-60732E48FCA1Q34553124-08A8D9E9-C695-4298-B0B2-8914FE615699Q34795051-0E0C5AAF-E96A-4D4E-AF4D-9FE8D03839AAQ34795057-87CB5C60-2ACD-41A4-8FB1-EBB05200EE0DQ34795098-B5D2FA12-F966-4A00-BB79-1242B99F3FF8Q34982096-1DB69C3E-9930-47BB-A8A6-3AD3E529381FQ34984130-E1FA68C2-35A8-4F4B-B07B-0354B8406835Q35532835-B6073C8C-15D1-4A73-953A-75A38C7BA13BQ35741969-7C51C961-A259-4D59-ABBD-1B80A052D7B3Q35796902-2B3B56BE-7F84-4B67-B868-2F858D94DFE9Q36013021-EC1A1F26-2B8C-45B5-AC4C-7E4C163E2622Q36190873-8C6D48CB-F52F-4936-87E2-177788158115Q36273189-58EF77AC-6A42-4510-B484-5F7434E6D56EQ36273565-C32001DA-B9F1-49FA-9010-FEBFBD65E4ECQ36273617-5320F4DD-6A5B-4B81-9829-7696468BDD9AQ36273622-88A38A9A-5EE6-4681-AA1B-0569E6E25A63Q36274729-32B692D5-017E-45F5-BBF0-601E3EC4DA75Q36575203-6C1D9491-245A-4755-BF1B-2CA7D4D1E779Q36575211-9E71A179-4956-4A2A-A234-863D9CA45254Q36575228-90A29A72-A1E0-40DA-8327-4FA820EA262AQ36659174-DB720E88-6B4D-4CBF-B3D2-76005C0F1673Q36874791-2200B2C9-6937-44EE-93A1-906262EF7747
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Brian Edlin
@ast
Brian Edlin
@en
Brian Edlin
@es
Brian Edlin
@nl
Brian Edlin
@sl
type
label
Brian Edlin
@ast
Brian Edlin
@en
Brian Edlin
@es
Brian Edlin
@nl
Brian Edlin
@sl
prefLabel
Brian Edlin
@ast
Brian Edlin
@en
Brian Edlin
@es
Brian Edlin
@nl
Brian Edlin
@sl
P108
P106
P108
P1153
7005907312
P21
P31
P496
0000-0001-8172-8797